RDPAC Urges Allowance For Use Of Non-essential Drugs In Public Healthcare Institutes
This article was originally published in PharmAsia News
The R&D-based Pharmaceutical Association Committee (RDPAC), which represents multinational pharma companies in China, recently urged the Chinese government to allow continued use of non-essential drugs in public hospitals, citing the price caps in its essential drug thresholds as a way to exclude non-domestic drugs
You may also be interested in...
Investors in surgical robotics company Auris say Johnson & Johnson failed to support the company per their merger agreement.
based firm, which markets Activa hand sanitizers, is offering Self+ immunity supplements in Brain, Energy and Unwind formulations in powder format for mixing with water.